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Introduction 
The acute dystonic reaction is usually 
the earliest and most dramatic kind of ex-
trapyramidal side effect of neuroleptics 
and related drugs, and is characterized by 
abnormal tonic contractions of muscle 
groups resulting in a variety of physical 
postural manifestations. When occurring, 
it is a source of considerable physical dis-
tress to the patient and professional dis-
tress to the clinician. 
Although neuroleptics, prescribed for 
psychiatric conditions, are by far the com-
monest drugs known to produce acute dys-
tonia, other drugs such as prochlor-
perazine, metoclopramide, tetrabenazine 
etc., prescribed for non-psychiatric condi-
tions, are also known to produce this side 
effect - the common factor is the ability of 
the drug to produce a central inhibition of 
dopaminergic neurotransmission. Less 
commonly, other drugs such as L-dopa, 
diphenylhydantoin, certain antihis-
taminics, certain antimalarials etc. are also 
known to produce acute dystonia (Rup-
niak et al 1986). 
Acute dystonia typically occur within 
48 hours of onset of treatment in 50% of 
cases, and within 5 days in 90% of cases 
(Rupnaik et al 1986), the risk is extremely 
low after a week of therapy (Winslow et al 
1986). The incidence of acute dystonia ap-
pears to vary widely from virtually nil with 
strongly anticholinergic neuroleptics such 
as thioridazine to nearly 50% with high po-
tency neuroleptics such as haloperidol., 
pooled data suggest that 2-5% of patients 
treated with antipsychotic drugs may de-
velop this side effect (Ayd, 1961, Sramek 
et al 1986, Rupniak et al 1986). A number 
of predisposing (e.g. younger age, male 
sex, positive past or family history of acute 
dystonia) and mitigating (e.g. lower initial 
dose of neuroleptic, lesser potency of 
neuroleptic, higher intrinsic anticholiner-
gic property of neuroleptic, concomittant 
anticholinergic therapy etc.) factors have 
been suggested in this connection (Rup-
niak et al 1986, Sramek et al 1986, Winslow 
et al 1986, McEvoy and Simpson 1987). 
There is as yet little discussion in liter-
ature on the incidences of different pat-
terns of dystonia, but it is generally ac-
cepted that tonic spasms of the muscula-
ture of the head and neck (e.g. oculogyric 
crises, torticollis etc.) are among the 
commonest manifestations, while involve-
ment of the limbs and trunk (e.g. opis-
thotonus, dystonic arm or leg postures 
* Correspondence and reprint requests 
1. Lecturer in Psychopharmacology 
2. Junior Resident in Psychiatry 
3. Dean, and Professor in Psychiatry _ 
National Institute of Mental Health and Neurosciences 
Bangalore 560 029, INDIA 416  NEUROLEPTIC- INDUCED LARYNGEAL DYSTONIA 
etc.) are relatively uncommon (Marsden et 
al, 1975). Of late, there has been report of 
a more unusual site of dystonia, viz., the 
larynx, which has been suggested to be as-
sociated with sudden death (Brown and 
Kocsis, 1984). 
In this paper we present a case of 
haloperidol-induced laryngeal dystonia 
and make certain recommendations in re-
lation to this side effect. 
Case Report 
Dr. R., a 43 old male, anaesthetist by 
profession, came under treatment for 
Paranoia (ICD-9 297.1) of about 10 years' 
duration. He had received short-term 
treatment with neuroleptics in the past 
with no ill effects. At the present occasion, 
he was started on 10 mg of haloperidol at 
bedtime. Approximately 36 hours after 
onset of therapy he began to complain of 
difficulty in breathing, the staff nurse in 
the ward conveyed to the resident in atten-
dance the news that the patient had become 
"hysterical' and was 'hyperventilating'. 
At first glance it seemed that the staff 
nurse's impression was correct. Being a 
doctor and aware of the implications of 
diagnosis and treatment, R. had been re-
luctant to accept neuroleptic therapy, 
furtheremore, he was known to possess 
histrionic traits. It therefore seemed that 
his restlessness and laboured breathing 
' could represent a hysterical reaction to the 
insult of being neuroleptized. 
Within the next 10 minutes or so 
further respiratory deterioration occurred. 
R. clearly and unambiguously indicated a 
source of respiratory blockage in the 
anatomical region of his larynx. Further, 
his toes inexplicably took up the position 
of intermittent flexion. The true nature of 
the dystonic symptoms was recognized and 
R. was injected with 50 mg of prom-
ethazine intravenously. The symptoms dis-
appeared within seconds of the injection. 
Subsequently, trihexyphenidyl in a 
dose of 2 mg twice daily was added to the 
treatment schedule. The dystonia did not 
recur despite continuation of haloperidol. 
Discussion 
Being an extremely unusual side ef-
fect, the incidence of laryngeal dystonic 
with neuroleptics is unknown. Rare 
though it is. this side effect has drawn at-
tention as a possible cause of sudden death 
with neuroleptics (Garveret al 1976, Flah-
erty and Lahmeyer 1978), while young 
men have been suggested to be more at 
risk, the true incidence of this side effect 
may be underrecognized (Brown and Koc-
sis 1984). Granted the lethal potential of 
laryngeal dystonia, we make certain re-
commendations, these are briefly discus-
sed below. 
At an educational level, postgraduate 
trainees in psychiatry must be routinely in-
structed about the possible occurrence of 
such a side effect during the early course of 
neuroleptic therapy, and about the iden-
tification of high risk situations. Students 
and staff nurses must also be educated 
about this side effect, the symptom of re-
spiratory distress should never be mista-
ken for hyperventilation or hysterical 
overlay, nurses should be aware of the 
emergency management (with intravenous 
promethazine) should such a side effect 
occur. It may also be worthwhile to target 
such education at medical undergraduates 
and postgraduate students, and at nursing 
staff and students in non-psychiatric dis-
ciplines, as acute dystonia is known to 
occur with a variety of non-psychiatric 
drugs as well. Last, but not least, in con-
tinuing medical education programmes 
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psychiatric expertise is imparted in a 'crash 
course' to non-specialists in the field, the 
occurrence and management of this side 
effect needs mention. 
At the patient level, as part of the gen-
eral instruction about the nature, effects 
and adverse reactions of neuroleptics, the 
patient and/or his guardian should be in-
formed about the possible occurrence of 
dystonia. A prescription for intravenous 
promethazine may also be routinely given, 
to be filled in at the nearest available med-
ical service in case of emergency. 
At the preventive level, it may not al-
ways be practical to initially administer 
either less potent or low doses of the 
neuroleptic, however, routine cover with 
anticholingergic drugs in the first two 
weeks of therapy may be of prophylactic 
value especially in high risk situations 
(Winslow et al 1986, Sramek et al 1986). 
In conclusion, given the low incidence 
of the symptom, the above recommenda-
tions may seem alarmistic, however, these 
recommendations would certainly go a 
long way in the prevention of dystonia, or 
in its early recognition and treatment. 
Thus, patient (and physician!) distress 
would be effectively curtailed. During the 
course of such a process, should even a 
single case of laryngeal dystonia be averted 
or successfully recognized and treated, the 
effort would have been worth the while. 
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